You are here: Industry Insights > Breast Cancer

News List

BioNTech: MammaTyper® Validated as Predictor for Response After Neoadjuvant Chemotherapy (NACT) in Patients with Early Breast Cancer (BC) b3cnewswire
November 29, 2018
BioNTech Diagnostics GmbH announced new results from a clinical performance evaluation study of the CE-marked IVD MammaTyper® which were presented at the European Society for Medical Oncology (ESMO) in Munich in October.(1,2)
Ribociclib could be used to treat glioblastoma europeanpharmaceuticalreview
November 21, 2018
Ribociclib, a drug approved to treat breast cancer, could be used to treat one of the deadliest forms of cancer – glioblastoma…
Philips launches integrated breast ultrasound solution with 4 screening tools fiercebiotech
November 02, 2018
Philips unveiled its first dedicated breast ultrasound solution, combining screening, elastography, precision biopsy and visual mapping tools.
Immunotherapy success for triple-negative breast cancer europeanpharmaceuticalreview
October 23, 2018
A combination of chemotherapy and immunotherapy could soon be used in NHS hospitals for triple-negative breast cancer to extend patient survival…
All about Targeted Drugs for Breast Cancer ! Xiaonisha
October 19, 2018
There have been 16 targeted drugs approved for breast cancer...
EU nod for Lilly’s new breast cancer drug pharmatimes
October 11, 2018
Eli Lilly’s CDK 4 and 6 inhibitor Verzenios has been approved in Europe for the treatment of certain metastatic breast cancers.
FDA lifts clinical hold from Mersana’s breast cancer trial fiercebiotech
September 18, 2018
The FDA has lifted the partial clinical hold it placed on a phase 1 trial of Mersana Therapeutics’ HER2-targeted antibody-drug conjugate (ADC). Regulatory officials put enrollment in the XMT-1522 breast cancer trial on hold in July after learning of the d
At Least 15 Men Near Ground Zero Have Breast Cancer drugs
September 13, 2018
At least 15 men who worked near Ground Zero after the 9/11 attacks have been diagnosed with breast cancer, a New York City law firm claims.
Late-stage study of Novartis' PI3K inhibitor BYL719 in breast cancer hits main goal firstwordpharma
August 24, 2018
Novartis said Thursday that a Phase III study of BYL719, also known as alpelisib, in certain postmenopausal women and men with hormone-receptor positive......
Talazoparib Beneficial in Patients With Advanced Breast Cancer drugs
August 16, 2018
Single-agent talazoparib provides significant benefit over standard chemotherapy for patients with advanced breast cancer and germline BRCA1/2 mutation, according to a study published online Aug. 15 in the New England Journal of Medicine.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 26 27 Next page